Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
FEMY
#3687
Femasys Inc. Common Stock
0.5
7
0.00%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
0.00%
Monthly Change
-3.39%
6 month change
+50.00%
Year Change
-65.45%
Previous Close
0.5
7
Open
0.5
7
Bid
Ask
Low
0.5
7
High
0.5
7
Volume
5
Markets
US Stock Market
Healthcare
FEMY
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
Dividend yield %
—
—
—
—
—
Payout ratio %
—
—
—
—
—
News
Femasys receives CPT code approval for infertility treatment
Femasys expands European presence with Swiss distribution deal
Femasys granted 180-day extension by Nasdaq to meet minimum bid price rule
Femasys partners with Refuah Health Center to expand FemaSeed fertility treatment
Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232
Pharmacyte Biotech CEO Silverman buys $80k in shares
Femasys receives FDA clearance for FemVue Controlled diagnostic device
PharmaCyte Biotech stock soars after successful Femasys stake sale
PharmaCyte Biotech sells Femasys stake, boosts cash position to $20 million
Laidlaw initiates Femasys stock with Buy rating on FemaSeed potential
FDA approves Femasys to continue pivotal trial for non-surgical birth control
Femasys begins post-market study for non-surgical birth control in EU